MA41048A - Utilité d'une protéine dans la prédiction d'effets in vivo - Google Patents

Utilité d'une protéine dans la prédiction d'effets in vivo

Info

Publication number
MA41048A
MA41048A MA041048A MA41048A MA41048A MA 41048 A MA41048 A MA 41048A MA 041048 A MA041048 A MA 041048A MA 41048 A MA41048 A MA 41048A MA 41048 A MA41048 A MA 41048A
Authority
MA
Morocco
Prior art keywords
predicting
usefulness
protein
vivo effects
vivo
Prior art date
Application number
MA041048A
Other languages
English (en)
Inventor
Christopher B Black
Kenneth R Brouwer
Jonathan P Jackson
Original Assignee
Qualyst Transp Solutions Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qualyst Transp Solutions Llc filed Critical Qualyst Transp Solutions Llc
Publication of MA41048A publication Critical patent/MA41048A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MA041048A 2014-10-07 2015-10-06 Utilité d'une protéine dans la prédiction d'effets in vivo MA41048A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462060916P 2014-10-07 2014-10-07

Publications (1)

Publication Number Publication Date
MA41048A true MA41048A (fr) 2017-08-15

Family

ID=55653702

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041048A MA41048A (fr) 2014-10-07 2015-10-06 Utilité d'une protéine dans la prédiction d'effets in vivo

Country Status (9)

Country Link
US (1) US20170205393A1 (fr)
EP (1) EP3204767A4 (fr)
JP (3) JP7097697B2 (fr)
CN (1) CN107003299A (fr)
AU (3) AU2015328138A1 (fr)
CA (1) CA2962491C (fr)
IL (1) IL251605B (fr)
MA (1) MA41048A (fr)
WO (1) WO2016057626A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018053406A1 (fr) * 2016-09-16 2018-03-22 Qualyst Transporter Solutions, Llc Procédés et systèmes de dépistage de composés candidats à la provocation potentielle d'une toxicité systémique ou hépatique
EP4220152A1 (fr) * 2020-12-18 2023-08-02 Chugai Seiyaku Kabushiki Kaisha Procédé de mesure de rapport relatif fu par analyse dynamique
WO2024020431A1 (fr) * 2022-07-20 2024-01-25 Symbiocell Tech, Llc Milieu de culture tissulaire spécifique d'espèce pour la propagation de cellules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US411077A (en) * 1889-09-17 Hugh garment turley
US4110077A (en) 1976-10-08 1978-08-29 Hoffmann-La Roche Inc. Determination of β-lipoproteins in blood serum with polyanethole sulfonate
US7601494B2 (en) * 1999-03-17 2009-10-13 The University Of North Carolina At Chapel Hill Method of screening candidate compounds for susceptibility to biliary excretion
ATE437360T1 (de) * 1999-03-17 2009-08-15 Univ North Carolina Screening-verfahren für kandidatenverbindungen auf empfänglichkeit für gallenexkretion
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
JP4913030B2 (ja) 2005-01-31 2012-04-11 株式会社バイオセレンタック 経皮吸収製剤、経皮吸収製剤保持シート、及び経皮吸収製剤保持用具
WO2011133529A1 (fr) * 2010-04-19 2011-10-27 The University Of North Carolina At Chapel Hill Prédicteurs de disposition pharmacocinétique et pharmacodynamique d'agents médiés par véhicule

Also Published As

Publication number Publication date
CA2962491A1 (fr) 2016-04-14
IL251605B (en) 2022-01-01
JP2017532066A (ja) 2017-11-02
CA2962491C (fr) 2023-03-21
WO2016057626A1 (fr) 2016-04-14
US20170205393A1 (en) 2017-07-20
JP7097697B2 (ja) 2022-07-08
AU2021269341A1 (en) 2021-12-09
EP3204767A4 (fr) 2018-02-28
EP3204767A1 (fr) 2017-08-16
AU2024204363A1 (en) 2024-07-11
AU2015328138A1 (en) 2017-04-27
JP2020182475A (ja) 2020-11-12
CN107003299A (zh) 2017-08-01
IL251605A0 (en) 2017-06-29
JP2023098948A (ja) 2023-07-11

Similar Documents

Publication Publication Date Title
DK3250703T3 (da) Ligeringsanalyser i væskefase
DK3359214T3 (da) Blodpumpe
DE112015002825A5 (de) Nicht-invasive Stoffanalyse
DK3180363T3 (da) Sirp-alpha-immunoglobulin fusionsproteiner
DK3424545T3 (da) Blodpumpe
DK3069739T3 (da) Blodpumpe
DK3069738T3 (da) Blodpumpe
DK3069740T3 (da) Blodpumpe
DK3107562T3 (da) P97-ids-fusionsproteiner
FR3020700B1 (fr) Methode pour la quantification de la presence de graisses dans une region du cœur
FR3007949B1 (fr) Crampon pour chaussure
DK3702450T3 (da) Protein
DK3259358T3 (da) Forøget proteinekspression
DK3206535T3 (da) Ligevægtsledforbindelse
DK3212495T3 (da) Flydende struktur
CL2016002136A1 (es) Proteinas de fusión uti
DK3229683T3 (da) Kapnometer
DK3099793T3 (da) Protein
MA41048A (fr) Utilité d'une protéine dans la prédiction d'effets in vivo
DK3271724T3 (da) Anvendelse af en standard til påvisning af proteinaggregater i en proteinfejlfoldningssygdom
FR3040595B3 (fr) Parasol suspendu demontable
FR3020033B1 (fr) Ensemble pour cycle
MA39011A (fr) Parasol pour chromothérapie
FR3023472B1 (fr) Ensemble pour l'arthroplastie du pied
ES1129405Y (es) Pista de padel